Back

Interplay among proton pump inhibitors, platelet reactivity and CYP2C19 genotyping in clopidogrel-treated patients after drug-eluting stent implantation

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Pharmacology in coronary artery disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Assistant Professor Ju Hyeon Kim

Korea University Anam Hospital, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Optimal antiplatelet therapy for patients after antiplatelet therapy-induced gastrointestinal bleeding: when to resume?
Professor R. Huang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
A meta-analysis on the efficacy of ticagrelor monotherapy after 3 months of dual antiplatelet therapy vs ticagrelor plus aspirin dual therapy on patients with ACS who underwent PCI
Doctor L. Galera (Manila, PH)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of under-dose non-vitamin K antagonist oral anticoagulant with atrial fibrillation undergoing PCI: Insights from a nationwide population-based cohort study
Ms G. Youk (Busan, KR)
Abstract Slides Video
Presentation thumbnail
Effectiveness and tolerability of trimetazidine 80mg once daily in patients with chronic coronary syndrome: the V-GOOD observational study
Professor L. Wolff Gowdak (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients
Associate Professor K. Trusinskis (Riga, LV)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacology in coronary artery disease

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Association between reduced risk of gastrointestinal bleeding related to proton pump inhibitor use and subsequent all-cause death in patients with percutaneous coronary intervention
thumbnail
Congress Presentation
Incidence and outcomes of new and persistent use of proton pump inhibitors following percutaneous coronary intervention: a retrospective population-based study
thumbnail
Congress Presentation
Clopidogrel vs. aspirin in the chronic maintenance period following percutaneous coronary intervention in high thrombotic and high bleeding risk patients:sub-analysis of the HOST-EXAM Extended study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources